CAL
JNJ icon

Capital Analysts LLC’s Johnson & Johnson JNJ Stock Holding History

Capital Analysts LLC’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.32M Sell
34,021
-3,750
-10% -$873K 0.22% 101
2025
Q4 		$7.82M Sell
37,771
-1,292
-3% -$255K 0.22% 102
2025
Q3 		$7.24M Sell
39,063
-2,081
-5% -$357K 0.21% 97
2025
Q2 		$6.29M Sell
41,144
-3,140
-7% -$483K 0.21% 96
2025
Q1 		$7.34M Buy
44,284
+1,257
+3% +$197K 0.27% 78
2024
Q4 		$6.22M Buy
43,027
+580
+1% +$89.9K 0.25% 80
2024
Q3 		$6.88M Buy
42,447
+2,171
+5% +$346K 0.28% 74
2024
Q2 		$5.89M Buy
40,276
+942
+2% +$140K 0.26% 81
2024
Q1 		$6.22M Buy
39,334
+406
+1% +$64.6K 0.29% 76
2023
Q4 		$6.1M Buy
38,928
+557
+1% +$85.4K 0.31% 75
2023
Q3 		$5.98M Sell
38,371
-13
-0% -$2.15K 0.33% 72
2023
Q2 		$6.35M Buy
38,384
+201
+0.5% +$32.4K 0.35% 68
2023
Q1 		$5.92M Buy
38,183
+4,769
+14% +$770K 0.34% 72
2022
Q4 		$5.9M Buy
33,414
+141
+0.4% +$24.3K 0.36% 59
2022
Q3 		$5.44M Buy
33,273
+3,462
+12% +$586K 0.37% 64
2022
Q2 		$5.29M Buy
29,811
+212
+0.7% +$37.8K 0.37% 64
2022
Q1 		$5.25M Buy
29,599
+364
+1% +$61.9K 0.33% 68
2021
Q4 		$5M Sell
29,235
-370
-1% -$60.6K 0.3% 70
2021
Q3 		$4.78M Buy
29,605
+353
+1% +$60.2K 0.31% 66
2021
Q2 		$4.82M Sell
29,252
-605
-2% -$100K 0.32% 66
2021
Q1 		$4.91M Buy
29,857
+5,905
+25% +$955K 0.34% 67
2020
Q4 		$3.77M Buy
23,952
+120
+0.5% +$17.7K 0.33% 67
2020
Q3 		$3.55M Sell
23,832
-423
-2% -$62.6K 0.34% 62
2020
Q2 		$3.41M Sell
24,255
-446
-2% -$65K 0.36% 65
2020
Q1 		$3.24M Buy
24,701
+19,301
+357% +$2.74M 0.4% 62
2019
Q4 		$788K Buy
5,400
+435
+9% +$59K 0.08% 171
2019
Q3 		$642K Sell
4,965
-424
-8% -$55.9K 0.07% 173
2019
Q2 		$751K Buy
5,389
+1,008
+23% +$140K 0.08% 168
2019
Q1 		$612K Buy
4,381
+371
+9% +$49.7K 0.07% 166
2018
Q4 		$518K Sell
4,010
-28,071
-88% -$3.92M 0.07% 161
2018
Q3 		$4.43M Buy
32,081
+1,142
+4% +$152K 0.51% 40
2018
Q2 		$3.75M Buy
30,939
+1,322
+4% +$165K 0.45% 45
2018
Q1 		$3.8M Buy
29,617
+1,942
+7% +$262K 0.47% 45
2017
Q4 		$3.87M Buy
27,675
+786
+3% +$109K 0.48% 43
2017
Q3 		$3.5M Buy
26,889
+1,152
+4% +$153K 0.47% 47
2017
Q2 		$3.4M Buy
25,737
+994
+4% +$127K 0.49% 32
2017
Q1 		$3.08M Buy
24,743
+12
+0% +$1.43K 0.49% 32
2016
Q4 		$2.85M Buy
24,731
+1,522
+7% +$176K 0.5% 42
2016
Q3 		$2.74M Buy
23,209
+64
+0.3% +$7.76K 0.51% 45
2016
Q2 		$2.81M Buy
23,145
+1,164
+5% +$132K 0.57% 46
2016
Q1 		$2.38M Buy
21,981
+2,034
+10% +$211K 0.48% 52
2015
Q4 		$2.05M Buy
19,947
+542
+3% +$54.5K 0.42% 60
2015
Q3 		$1.81M Buy
19,405
+2,137
+12% +$207K 0.35% 73
2015
Q2 		$1.68M Buy
17,268
+828
+5% +$82.9K 0.34% 71
2015
Q1 		$1.65M Buy
16,440
+872
+6% +$88.7K 0.34% 63
2014
Q4 		$1.63M Sell
15,568
-202
-1% -$21.3K 0.36% 63
2014
Q3 		$1.68M Sell
15,770
-183
-1% -$19K 0.39% 60
2014
Q2 		$1.67M Sell
15,953
-145
-0.9% -$14.7K 0.41% 59
2014
Q1 		$1.58M Buy
16,098
+2,107
+15% +$195K 0.41% 62
2013
Q4 		$1.28M Buy
13,991
+1,340
+11% +$123K 0.35% 78
2013
Q3 		$1.1M Sell
12,651
-574
-4% -$51.5K 0.33% 73
2013
Q2 		$1.14M Buy
+13,225
New +$1.12M 0.36% 64

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Analysts LLC's JNJ Position: Q1 2026 in Review

Capital Analysts LLC reduced its Johnson & Johnson (JNJ) stake by 9.9% in Q1 2026, selling an estimated $873K and leaving 34,021 shares worth $8.32M. The position accounts for 0.22% of the portfolio, ranked #101.

Capital Analysts LLC first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital Analysts LLC held 34,021 shares of Johnson & Johnson worth $8.32M as of Q1 2026.
  • Capital Analysts LLC sold 3,750 Johnson & Johnson shares in Q1 2026, an estimated $873K.
  • Johnson & Johnson made up 0.22% of Capital Analysts LLC's portfolio in Q1 2026, its #101 holding.
  • Capital Analysts LLC first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.